COVID: Booster injection appears to be effective against Omicron, according to Pfizer
A booster shot of Pfizer and BioNTech’s coronavirus vaccination, according to Pfizer and BioNTech, will provide good resistance against the new Omicron form.
After a modest trial, the firms found that three doses generated a similar number of antibodies against Omicron as two doses against other variations. According to the World Health Organization, vaccines against severe Omicron cases should still work (WHO).
Researchers from all over the world are piecing together Omicron data. It’s the coronavirus with the most severe mutations ever known.
A third dose of the vaccine, according to Pfizer CEO Albert Bourla, will improve protection against the variant.
Pfizer and BioNTech, on the other hand, stressed that the findings were preliminary and that they would continue to collect data and evaluate real-world effectiveness. They also stated that they were working on an Omicron specific immunisation that will be ready for delivery in 100 days, pending regulatory approval.
The immunisation produced significantly less neutralising antibodies against Omicron than the original Covid strain, according to both the Pfizer/BioNTech study and a recent, unpublished South African analysis.
According to Pfizer/BioNTech, a third treatment boosted the amount of protection against other variations by a factor of 25, making it comparable to two treatments.
Omicron was first detected in South Africa, where there has been a steady increase in the number of patients who have caught COVID. According to a spokeswoman for UK Prime Minister Boris Johnson, early signs suggest Omicron could be more transmissible than the present Delta strain. Omicron’s ability to induce major sickness, on the other hand, is still unknown.
According to Dr Ryan of the World Health Organization, Omicron did not make patients sicker than Delta or other strains, but it was milder.
According to Dr Anthony Fauci, the top US infectious disease expert, early research suggests Omicron may be more transmissible but less severe. Since the outbreak began, there have been over 267 million coronavirus illnesses and over five million deaths globally, according to data from Johns Hopkins University.